Guidelines for lowering lipids to reduce coronary artery disease risk: A comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals - Discussion

被引：0
|
作者：
Davidson, MH [1 ]
Wood, DA
Paoletti, R
Hobbs, R
Shepherd, J
Brown, WV
Hunninghake, DB
McKenney, JM
机构：
[1] Chicago Ctr Clin Res, Chicago, IL USA
[2] Charing Cross Hosp, Natl Heart & Lung Inst, London, England
[3] Univ Milan, Milan, Italy
[4] Univ Birmingham, Birmingham, W Midlands, England
[5] Univ Glasgow, Glasgow, Lanark, Scotland
[6] Emory Univ, Sch Med, Atlanta, GA USA
[7] Univ Minnesota, Minneapolis, MN USA
[8] Natl Clin Res, Richmond, VA USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 91卷 / 5A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：17C / 19C
页数：3
相关论文
共 50 条
  • [1] Guidelines for lowering lipids to reduce coronary artery disease risk: A comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals
    Shepherd, J
    Hunninghake, DB
    Barter, P
    McKenney, JM
    Hutchinson, HG
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (5A): : 11C - 17C
  • [2] Guidelines for lowering lipids to reduce coronary artery disease risk: A comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals (Reprinted from Am J Cardiol, vol 91, pg 11C-19C, 2003)
    Shepherd, J
    Hunninghake, DB
    Barter, P
    McKenney, JM
    Hutchinson, HG
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (03) : 115 - 121
  • [3] Lipid and apolipoprotein ratios: Association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin - Discussion
    Stein, EA
    Shepherd, J
    Barter, P
    Hobbs, R
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (5A): : 23C - 24C
  • [4] LIPID LOWERING EFFICACY OF ROSUVASTATIN VS ATORVASTATIN IN PATIENTS WITH CORONARY ARTERY DISEASE
    Ostergren, J.
    Malmstrom, R.
    Jorgensen, L.
    Walldius, G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 205 - 205
  • [5] Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial
    McKenney, JM
    Jones, PH
    Adamczyk, MA
    Cain, VA
    Bryzinski, BS
    Blasetto, JW
    CURRENT MEDICAL RESEARCH AND OPINION, 2003, 19 (08) : 689 - 698
  • [6] Lipid-lowering therapy for patients with or at risk of coronary artery disease
    Kjekshus, J
    Pedersen, TR
    Tobert, JA
    CURRENT OPINION IN CARDIOLOGY, 1996, 11 (04) : 418 - 427
  • [7] Achieving optimum lipid-lowering goals in patients with vascular disease
    See R.
    Piana R.N.
    Current Cardiovascular Risk Reports, 2009, 3 (5) : 323 - 330
  • [8] Lipid and apolipoprotein ratios: Association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin
    Rader, DJ
    Davidson, MH
    Caplan, RJ
    Pears, JS
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (5A): : 20C - 23C
  • [9] Underutilization of lipid-lowering therapy in coronary artery disease
    Batalla, A
    Hevia, S
    Reguero, JR
    Cubero, GI
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (17) : 2683 - +
  • [10] Endothelial lipase genetic polymorphisms and the lipid-lowering response in patients with coronary artery disease on rosuvastatin
    Cai, Gaojun
    Zhang, Bifeng
    Shi, Ganwei
    Weng, Weijin
    Yang, Liping
    Xue, Sheliang
    LIPIDS IN HEALTH AND DISEASE, 2016, 15
12345